U 3618 (Vantin 200 mg)
Generic Name: cefpodoxime
Pill imprint U 3618 has been identified as Vantin 200 mg.
Vantin is used in the treatment of skin infection; bronchitis; gonococcal infection, disseminated; bladder infection; sinusitis (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Vantin 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for U 3618
- Generic Name:
- 200 mg
- 14.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- carboxymethylcellulose calcium
FD&C Yellow No. 6
sodium lauryl sulfate
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|55289-0390||PDRX Pharmaceuticals Inc (repackager)|
|54569-4783||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
More about Vantin (cefpodoxime)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.